ASML Holding NV (ASML) shares slipped 0.44% to €1,501.80 on Euronext Amsterdam on Wednesday, as the initial excitement over Elon Musk's Terafab endorsement gave way to cautious profit-taking. The stock had surged 3.58% on Monday following Musk's praise of ASML as "arguably the greatest company in Europe," but gave back 0.41% on Tuesday and continued to edge lower on Wednesday.
Investors are now questioning whether the Terafab buzz will translate into tangible orders for ASML's extreme ultraviolet (EUV) lithography systems, which are critical for manufacturing advanced AI chips. The company's unique technology uses short-wavelength light to create ultra-fine chip patterns, positioning it as a key enabler in the AI supply chain. However, the stock's recent rally—up 63% year-to-date and 119% over the past year—has left little room for error, with any signs of slowing AI-related orders or shipment delays likely to trigger a correction.
Q2 Earnings: The Key Catalyst
All eyes are now on ASML's second-quarter results, due July 15. The report will provide crucial data on equipment orders, gross margins, and any commentary on export controls. Analysts expect the Q2 update to be the primary driver of the stock's next move, as it will reveal whether the strong demand narrative is translating into actual financial performance. In April, ASML raised its 2026 revenue target to €36-€40 billion and projected a gross margin of 51%-53%, underscoring the company's confidence in its growth trajectory.
CEO Christophe Fouquet noted in the Q1 update that "demand for chips is outpacing supply," with customers accelerating capacity expansion plans for 2026 and beyond. This has fueled optimism that ASML will continue to benefit from the AI boom, but the high valuation leaves the stock vulnerable to any disappointment.
Analyst Upgrades and Market Sentiment
Despite the recent dip, analyst sentiment remains bullish. BofA raised its price target to €1,921 from €1,710, while JPMorgan increased its target to €1,900 from €1,515. Morgan Stanley also lifted its target to €1,660 from €1,400. The upgrades are based on confidence in EUV capacity expansion and shipment growth. However, the stock's market cap has swelled to over €580 billion, making it one of the most valuable companies in Europe.
Challenges Ahead: High-NA EUV and Export Controls
While customer demand appears robust, there are headwinds. TSMC CEO C.C. Wei noted that while the company has purchased ASML's High-NA EUV tools, it does not yet need them due to high costs. High-NA (high numerical aperture) technology is a next-generation EUV optics system for even finer chip patterns, but its adoption may be slower if buyers balk at the price tag. Additionally, export controls remain a wildcard. ASML has said its 2026 outlook incorporates potential impacts from policy changes, but any escalation could hit AI-related capital expenditure trends.
The Terafab hype, while boosting sentiment in the short term, may not translate into immediate orders. Musk's planned appearance at an internal ASML tech event has also stirred some controversy, with staff pushback reported by NL Times. ASML clarified that the event is for employees only and not a disclosure opportunity for investors.
In summary, ASML's stock is at a critical juncture. The Q2 report on July 15 will be the pivotal catalyst, determining whether the AI-fueled rally has more room to run or if the market has priced in too much growth. Until then, investors are likely to remain cautious, weighing the potential of Terafab against the realities of shipping constraints and policy risks.
